Cost-effectiveness analyses using real-world data: an overview of the literature

Kevin Bowrin, Jean-Baptiste Briere, Pierre Lévy, Aurélie Millier, Emilie Clay and Mondher Toumi
Additional contact information
Kevin Bowrin: Bayer S.A.S. [France] - Bayer AG [Germany]
Jean-Baptiste Briere: Bayer AG [Germany]
Pierre Lévy: LEDa - Laboratoire d'Economie de Dauphine - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres
Aurélie Millier: Creativ-Ceutical France - Creativ-Ceutical, Creativ-Ceutical - Creativ-Ceutical SARL
Emilie Clay: Creativ-Ceutical France - Creativ-Ceutical, Evaluation des systèmes de soins et santé perçue - Université de la Méditerranée - Aix-Marseille 2
Mondher Toumi: Laboratoire de Santé Publique - Université de la Méditerranée - Aix-Marseille 2, Pharmaco-Epidémiologie - Université Bordeaux Segalen - Bordeaux 2 - INSERM - Institut National de la Santé et de la Recherche Médicale, CEReSS - Centre d'études et de recherche sur les services de santé et la qualité de vie - AMU - Aix Marseille Université

Post-Print from HAL

Keywords: Economic evaluation; modeling; real-world; literature review (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Published in Journal of Medical Economics, 2019, 22 (6), ⟨10.1080/13696998.2019.1588737⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02292296

DOI: 10.1080/13696998.2019.1588737

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().